Adjuvant chemotherapy improves survival amongst octogenarians following resection of colorectal adenocarcinoma
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.18715 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Dhanushke Fernando und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, St John of God Subiaco Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenocarcinoma, Australasian People. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The Australian population is ageing, with an increasing number of patients diagnosed with colorectal cancer in their eighth decade. This group represents a challenging cohort to deliver multidisciplinary care, with increased morbidity and mortality related to surgical and oncological therapies. This project aimed to compare surgical and oncological outcomes in octogenarian and non‐octogenarian patients with colorectal cancer.
Methods
A matched case–control retrospective review of a prospectively maintained institutional database of colorectal cancer patients treated between 2005 and 2021 was conducted. Patient demographics, treatment details, peri‐operative complications, and long‐term survival were reported. The primary outcome, cancer‐specific survival, was investigated using time‐to‐event analysis and interrogated with multivariate regression.
Results
There were 747 patients included in the study. There was no difference in five‐year cancer‐specific survival and recurrence‐free survival between cohorts. Multivariate analysis for octogenarians confirmed a significant hazard signal associated with worsening cancer stage and a survival benefit associated with the administration of adjuvant therapy. However, we noted that stage‐matched octogenarian patients received less adjuvant treatment compared to non‐octogenarians.
Conclusion
Octogenarians undergoing treatment for colorectal cancer have similar cancer‐specific survival and recurrence‐free survival to non‐octogenarians. Our study demonstrates a survival benefit when adjuvant therapy is provided to octogenarians, despite only half of this cohort receiving therapy compared to their younger peers. Further research into adjuvant therapy with surgical resection for CRC in older Australians is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, St John of God Subiaco Hospital, Perth, Western Australia, Australia.
- Medical School, The University of Western Australia, Perth, Western Australia, Australia.
- School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia.
- Colorectal Surgery Unit, Fiona Stanley Hospital, Perth, Western Australia, Australia.
ORCID-Profile: Dhanushke Fernando, Joseph Hanna, Ryan Cohen
Zitieren
APA
Fernando, D., Hanna, J., Cohen, R., & Ryan, J. (2024). Adjuvant chemotherapy improves survival amongst octogenarians following resection of colorectal adenocarcinoma. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18715
Vancouver
Fernando D, Hanna J, Cohen R, Ryan J. Adjuvant chemotherapy improves survival amongst octogenarians following resection of colorectal adenocarcinoma. ANZ Journal of Surgery. 2024. doi:10.1111/ans.18715
BibTeX
@article{Fernando2024,
author = {Fernando, Dhanushke and Hanna, Joseph and Cohen, Ryan and Ryan, Jennifer},
title = {Adjuvant chemotherapy improves survival amongst octogenarians following resection of colorectal adenocarcinoma},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.18715}
}
EUVIMED